Home>Recartix Plus>recartix plus 750 mg/50 mg/250 mg tablet

Recartix Plus 750 mg/50 mg/250 mg Tablet

icon
iconPrescription Required

Primary uses of Recartix Plus 750 mg/50 mg/250 mg Tablet

MRP
117
₹11.7/Tablet
10 tablets in 1 strip
ADD TO CART

Medicine Overview of Recartix Plus Tablet

uses

Uses of Recartix Plus Tablet

Recartix Plus 750 mg/50 mg/250 mg Tablet is used in the treatment of osteoarthritis.
uses

Recartix Plus Tablet side effects

Common

Nausea, Diarrhoea, Constipation, Indigestion, Heartburn, Urine discolouration.

uses

How to use Recartix Plus Tablet

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Recartix Plus 750 mg/50 mg/250 mg Tablet is to be taken with food.

How Recartix Plus Tablet works

Recartix Plus 750 mg/50 mg/250 mg Tablet is a combination of three medicines: Glucosamine, Diacerein and Methyl Sulfonyl Methane which treat osteoarthritis. Glucosamine and Diacerein are proteoglycan synthesis stimulators while Methyl Sulfonyl Methane (MSM) is a nutritional supplement. Together, they help in the building of cartilage (the soft tissue around the joints) leading to joint repair. MSM additionally lowers inflammation (swelling) of the joints.

In Depth Information on Recartix Plus Tablet

Recartix Plus Tablet related warnings
Special precautions for Recartix Plus Tablet
Alcohol
Interaction with alcohol is unknown. Please consult your doctor.
Pregnancy
Unknown. Human and animal studies are not available. Please consult your doctor.
Lactation
No information is available on the use of Recartix Plus 750 mg/50 mg/250 mg Tablet during lactation. Please consult your doctor.
Driving
It is not known whether Recartix Plus 750 mg/50 mg/250 mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Kidney
Recartix Plus 750 mg/50 mg/250 mg Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Recartix Plus 750 mg/50 mg/250 mg Tablet may not be needed in these patients. Please consult your doctor.
Liver
UNSAFE
Recartix Plus 750 mg/50 mg/250 mg Tablet is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.

Patient Concerns

No Patient Concerns found for this medicine

User Submitted Feedback For Recartix Plus 750 mg/50 mg/250 mg Tablet

Survey Participants: 2
Disclaimer
“The following are the results of on-going survey on 1mg.com for Recartix Plus 750 mg/50 mg/250 mg Tablet. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
One of the following vendor pharmacies will deliver Recartix Plus 750 mg/50 mg/250 mg Tablet: BDN, LCC, MDH, QLF, CHP, MMS, HMP, SJP, UMP, SWP, TNH, SHC, PLT, SCH, GTC, MDO, PWN, INC, AGT, DHR, HSP, RWP, GNC, BSN, AMR, DPL, GHR, AAR, BBS, PTI, DYG, NTB, OIP, EQN, DAO, STA, NXG, EVP, AYM, FGH, BAP, NVL, BLE, ADT, HGI, SHP, HEX, WSI, BMJ, PNT, QTM, HPC, TOM, ZVP, P2P, SVS, KHH, NVY, SWA, SGC, PMA, DPP, PEN, NDP, RDR, SHD, THP, SVH, MPC, RUS, RHW, JVO, ENP, DLP, BTM, MAK, MLC, AAY, JIV, ARD, TRP, SAF, VRS, SGH, PPR, HZF, ATL, RPP, KHC, SSA, HIP, PRN, CLT, VDH, SBL, NAS, JSL, SPD, WHL, SLN, DGN, TFP, RJH, ANT, VNS, RKS, SDM, SYN, OLT, GPT, RDH, ATP, DVH, IAD, ESY, ABP, BIO, EMB, LHA, GTK, RPI, AYU, BHP, OWP, MSD, HNP, KMC, HTS, OHM, SBA, NSL, DFP, RSS, MAM, 9T9, MAX, BHM, HBV, RHL, USF, JVN, ZEL, GBL, IPL, NNH, SRG, RSA, PVP, BAL, HAT, GPP

Substitutes for Recartix Plus 750 mg/50 mg/250 mg Tablet

₹9.95/Tablet
save 15%
Ostovit DM Tablet
Geno Pharmaceuticals Ltd
₹10.5/Tablet
save 10%
₹10.6/Tablet
save 9%
Bonjofit Tablet
Winsome Laboratories Pvt Ltd
₹11/Tablet
save 6%
Chondryl 750 mg/50 mg/250 mg Tablet
Ar-Ex Laboratories Pvt Ltd
₹12/Tablet
3% costlier
Top Rheumatologists
5.0
Dr. Prasan Deep Rath
MBBS, MD, Fellowship, Certification, Fellowship
4.4
4.3
Dr. Sumeet Agrawal
MBBS, MD, DM
4.9
Dr. Naval Mendiratta
MBBS, MD, Fellowship
4.7
cross img